There is one thing the bashers are right about, it won't be that long before we know for certain that we have success. At the latest 2025 should have approvals from all the regulators we're working with, the UK decision should certainly come by second quarter this year, but without knowing the company's intentions with the other regulators, it's impossible to say if there will be others this year.
I still believe that the Annual Meeting should answer much of this, some of it may be answered by the Annual Report, which I believe should be out near the end of this month, or perhaps early March. As for the Annual Meeting, they've delayed so long that they might just delay till they have a UK decision and they probably could call it the meeting for both 2023 and 2024, not the right way to do it, but on the OTC it would be okay.
I don't think I've ever been in a Nasdaq or NYSE stock that didn't hold quarterly conference calls when issuing quarterly reports, but I don't know that it's required. If it is, someone please verify that. We know LP wants to make this move, frankly when we're selling at a price that's needed to justify making the move to one of those exchanges, I believe that she'll willingly speak to us quarterly, as well as being invited to many Institutional and Brokerage conferences. We'll go from almost complete silence to how many times is she speaking this month, or this week.
As I see it, by March we should know something as the Annual Report will be out, if at that time the company isn't committing to a date for the Annual Meeting, whether they say it or not, they're waiting for the word from the UK. I also believe that on getting the word from the UK they'll issue a PR and hold a webcast within a day or two, it won't be the Annual Meeting, but it clearly will be very informative.
Gary
